MCL1 and B-cell chronic lymphocytic leukemia: These findings along with the evidence that both Mcl-1 and eIF4E contribute to survival and chemotherapy resistance of CLL cells highlight the importance to target Notch signaling for CLL treatment, especially in combination with agents whose poor efficacy is mainly due to the elevated Mcl-1 expression and eIF4E activity detected in these leukemic cells.